|
|
|
| |
|
|
| |
|
|
| |
Collins AJ, Ebben
JP, Dalleska FW, Chen S-C:
Hospitalization
outcomes associated with providers practicing
reuse with and without bleach cleaning.
Journal of the American
Society of Nephrology 12: Page 324A, September
2001 |
|
| |
|
|
| |
Collins AJ, Ebben
JP, Dalleska FW:
Bleach
versus no bleach: Does it make a difference?
Journal of the American
Society of Nephrology 12: Page 324A, September
2001 |
|
| |
|
|
| |
Gilbertson DT,
Collins AJ, Ebben JP:
Medicare
gap insurers cover a greater portion of the
costs of care as United States dialysis patients
move to the outpatient setting.
Journal of the American
Society of Nephrology 12: Page 205A, September
2001 |
|
| |
|
|
| |
Li S, Snyder JJ,
Gilbertson DT, Collins AJ:
Effect
of hematocrit level on first hospitalization
events in the peritoneal dialysis population.
Journal of the American
Society of Nephrology 12: Page 220A, September
2001 |
|
| |
|
|
| |
Snyder JJ, Gilbertson
DT, Collins AJ:
Influenza
vaccination in the dialysis population: A
comparison of hemodialysis and peritoneal
dialysis.
Journal of the American
Society of Nephrology 12: Page 246A, September
2001 |
|
| |
|
|
| |
Snyder JJ, Gilbertson
DT, Collins AJ:
Cancer
screening in the dialysis population, a comparison
of HD and PD.
Journal of the American
Society of Nephrology 12: Page 246A, September
2001 |
|
| |
|
|
| |
Snyder JJ,
Gilbertson DT, Collins AJ:
Diabetic
care in the dialysis population, a comparison
of HD and PD.
Journal of the American
Society of Nephrology 12: Page 246A, September
2001 |
|
| |
|
|
| |
Li S, Snyder JJ,
Gilbertson DT, Collins AJ:
Cardiac
outcomes comparing peritoneal dialysis and
hemodialysis patients.
Journal of the American
Society of Nephrology 12: Page 335A, September
2001 |
|
| |
|
|
| |
Xue JL, Ebben JP,
St. Peter WL, Constantini EG, Collins AJ:
Correction
of anemia with erythropoietin during the two-year
pre-ESRD period: Cardiac disease associated
with pre-ESRD EPO treatment.
Journal of the American
Society of Nephrology 12: Page 259A, September
2001 |
|
| |
|
|
| |
Xue JL, Ebben JP,
St. Peter WL, Constantini EG, Collins AJ:
Correction
of anemia with erythropoietin during the two-year
pre-ESRD period: Post-ESRD mortality.
Journal of the American
Society of Nephrology 12: Page 259A, September
2001 |
|
| |
|
|
| |
Xue JL, Ebben JP,
St. Peter WL, Constantini EG, Collins AJ:
Correction
of anemia with erythropoietin during the two-year
pre-ESRD period: II. Hematocrit and serum
albumin levels prior to ESRD.
Journal of the American
Society of Nephrology 12: Page 258A, September
2001 |
|
| |
|
|
| |
Xue JL, Ebben JP,
St. Peter WL, Constantini EG, Collins AJ:
Correction
of anemia with erythropoietin during the two-year
pre-ESRD period: I. EPO prescription by physician
specialty.
Journal of the American
Society of Nephrology 12: Page 257A, September
2001 |
|
| |
|
|
| |
Liu J, Li S, Ebben
JP, Manning WG, Ma JZ, Collins AJ:
Economic
impacts of anemia correction and geographic
variability of expenditure in hemodialysis
patients.
Journal of the American
Society of Nephrology 12: Page 222A, September
2001 |
|
| |
|
|
| |
St. Peter WL, Xue
J, Ebben J, Collins A:
Pre-end-stage
renal disease erythropoietin use predicts
hospitalization in the periods before and
after end-stage renal disease diagnosis.
Journal of the American
Society of Nephrology 12: Page 248A, September
2001 |
|
| |
|
|
| |
Collins AJ, Li
S, St. Peter WL, Ebben J, Liu J:
Higher
hematocrits are associated with lower hospitalizations
for congestive heart failure, fluid overload,
and cardiomyopathy.
Journal of the American
Society of Nephrology 12: Page 323A, September
2001 |
|
| |
|
|
| |
Collins AJ, Li
S, St. Peter WL, Ebben JP, Liu J:
Higher
hematocrits are associated with lower cardiovascular
ischemic events.
Journal of the American
Society of Nephrology 12: Page 323A, September
2001 |
|
| |
|
|
| |
Collins AJ, Li
S, St. Peter WL, Ebben JP, Liu J:
Higher
hematocrits are associated with lower vascular
access complications.
Journal of the American
Society of Nephrology 12: Page 197A, September
2001 |
|
| |
|
|
| |
Collins AJ, Li
S, St. Peter WL, Ebben JP, and Liu J:
Higher
hematocrits are associated with lower infectious
hospitalization risk.
Journal of the American
Society of Nephrology 12: Page 323A, September
2001 |
|
| |
|
|
| |
St. Peter WL, Roberts
TL, Collins AJ:
Effect
of intravenous iron utilization on erythropoietin
doses and hematocrit levels in prevalent hemodialysis
patients.
Journal of the American
Society of Nephrology 12: Page 247A, September
2001 |
|
| |
|
|
| |
St. Peter WL, Xue
JL, Ebben JP, Collins AJ:
Pre-ESRD
erythropoietin use predicts Medicare expenditures
in the periods before and after end-stage
renal disease diagnosis.
Journal of the American
Society of Nephrology 12: Page 247A, September
2001 |
|
| |
|
|
| |
St. Peter WL, Robert
TL, Collins AJ:
Hematocrit,
erythropoietin and iron use trends in hemodialysis
versus peritoneal dialysis patients.
Journal of the American
Society of Nephrology 12: Page 247A, September
2001 |
|
| |
|
|
| |
Roberts TL, St.
Peter WL, Frazier ET, Collins AJ:
Early
hematocrit correction among incident hemodialysis
patients: Patterns of erythropoietin dosing
and iron therapy.
Journal of the American
Society of Nephrology 12: Page 241A, September
2001 |
|
| |
|
|
| |
Roberts TL, St.
Peter WL, Frazier ET, Collins AJ:
Higher
hematocrit at dialysis initiation is associated
with lower erythropoietin dosing in the first
nine months of dialysis.
Journal of the American
Society of Nephrology 12: Page 241A, September
2001 |
|
| |
|
|
| |
Roberts TL, Obrador
GT, Frazier ET, Pereira BJG, St. Peter WL,
Collins AJ:
Trends
in anemia at dialysis initiation.
Journal of the American
Society of Nephrology 12: Page 240A, September
2001 |
|
| |
|
|
| |
Collins AJ, Li
S, St. Peter WL, Ebben JP, Manning WG:
Incident
hemodialysis patient hematocrit outcomes:
Comparison of cohorts 1991-95 vs. 1996-98.
Journal of the American
Society of Nephrology 12: Page 323A, September
2001 |
|
| |
|
|
| |
Snyder J, Vonesh
E, Collins AJ:
Mortality
outcomes using an integrated care approach.
IX Congress
of the International Society for Peritoneal
Dialysis, Montreal, Canada, June 26-29, 2001 |
|
| |
|
|
| |
Li S, Ebben J,
Chen S, Roberts T, Collins AJ:
Clinical outcome in
incident peritoneal dialysis patients with
anemia treatment.
IX
Congress of the International Society for
Peritoneal Dialysis, Montreal, Canada, June
26-29, 2001 |
|
| |
|
|
| |
Xue JL, Ebben J,
St. Peter W, Collins A:
An
association of pre-end-stage renal disease
epoetin treatment with post-ESRD mortality.
National Kidney Foundation
Clinical Nephrology Meetings, Orlando, Florida,
April 17-22, 2001 |
|
| |
|
|
| |
Xue JL, Ebben J,
St. Peter W, Collins A:
Erythropoietin
treatment of anemia in pre-end-stage renal
disease patients by physician practice.
National Kidney Foundation
Clinical Nephrology Meetings, Orlando, Florida,
April 17-22, 2001 |
|
| |
|
|
| |
Xue JL, Ebben J,
Dalleska F, St. Peter W, Collins AJ:
Diagnosis and treatment
of anemia in the pre-end-stage renal disease
period.
Annual
Conference on Dialysis, New Orleans, Louisiana,
February 19-21, 2001 |
|
| |
|
|
|
| |
|
